Medication Affordability and Patent Integrity Act
This act aims to increase transparency in drug approval and patent processes, potentially leading to lower medication costs. Pharmaceutical companies will need to disclose more patent information, facilitating the introduction of cheaper generic alternatives. This could give citizens easier access to more affordable medications.
Key points
Drug companies must disclose consistent patent information to both the patent office and the food and drug agency, increasing transparency.
If a company fails to disclose required information, others can defend against patent infringement claims, potentially speeding up access to generic drugs.
The goal is to lower drug prices by fostering competition and preventing patent misuse.
Introduced
Citizen Poll